Veterinary Oncologists Join Purdue University

Purdue University has welcomed Dr. Nick Dervisis and Dr. Shawna Klahn, a husband-wife veterinary oncology team, who are set to enhance comparative oncology research and education within its College of Veterinary Medicine after relocating from Virginia Tech. Their expertise in tumor ablation devices is expected to advance cancer treatment in animals significantly. Meanwhile, scientists at the University of Leeds have developed a revolutionary nanosurgical tool capable of observing individual living cancer cells in real-time, which could lead to more effective treatments by allowing repeated sampling without destroying the cells. Additionally, advancements in nanomedicine are being explored to trigger cancer cell death through engineered nanoparticles, while biomaterials are emerging as versatile platforms for targeted cancer therapies and personalized medicine. Startups like New Phase are also utilizing nanotechnology, specifically electromagnetic hyperthermia, to improve treatment outcomes for metastatic cancer patients. Collectively, these innovations reflect the dynamic progress being made in cancer research and treatment methodologies.